Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Shares Issued (2016 - 2025)

Plus Therapeutics has reported Shares Issued over the past 15 years, most recently at $3.0 million for Q4 2025.

  • Quarterly Shares Issued changed N/A to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.6 million through Dec 2025, up 1897.69% year-over-year, with the annual reading at $22.6 million for FY2025, 211.29% up from the prior year.
  • Shares Issued was $3.0 million for Q4 2025 at Plus Therapeutics, down from $18.7 million in the prior quarter.
  • Over five years, Shares Issued peaked at $18.7 million in Q3 2025 and troughed at -$2.3 million in Q3 2023.
  • The 4-year median for Shares Issued is $1.2 million (2023), against an average of $3.5 million.
  • The largest YoY upside for Shares Issued was 4296.77% in 2023 against a maximum downside of 170.56% in 2023.
  • A 4-year view of Shares Issued shows it stood at $7.2 million in 2021, then crashed by 91.64% to $600000.0 in 2022, then surged by 66.67% to $1.0 million in 2023, then skyrocketed by 200.3% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Shares Issued are $3.0 million (Q4 2025), $18.7 million (Q3 2025), and $882000.0 (Q1 2025).